Most Read Articles
04 Oct 2020
Obesity does not appear to be strongly correlated with an increased risk for febrile neutropaenia during levofloxacin prophylaxis in patients with haematological malignancies receiving intermediate-risk myelosuppressive chemotherapy, suggests a study.
Roshini Claire Anthony, 3 days ago

Initiation or switch to the single-tablet regimen of bictegravir/emtricitabine/tenofovir alafenamide (TAF) led to low HIV-1 RNA viral load in people living with HIV (PLHIV), according to the BICSTaR study presented at HIV Glasgow 2020.

09 Nov 2020
Use of corticosteroids appears to be an effective treatment for paediatric drug reaction with eosinophilia and systemic symptoms (DRESS), suggest the results of a recent study. In severe cases, corticosteroids used in conjunction with intravenous immunoglobulin result in fast clinical improvement.
07 Aug 2020
Concomitant treatment with a nonsteroidal anti-inflammatory drug (NSAID) following myocardial infarction (MI) is associated with a higher risk of cardiovascular and bleeding events, a study has shown.

Adding corticosteroid to tocilizumab equates to better survival in severe COVID-19

11 Nov 2020

Severe COVID-19 patients receiving tocilizumab (TCZ) for systemic host-immune inflammatory response syndrome see survival benefits with add-on corticosteroid therapy, as shown in a study.

The real-world retrospective analysis included 186 consecutive adult patients (mean age, 64.3 years; 69.4 percent male) with severe COVID-19 being treated with tocilizumab. Of these, 129 (87.8 percent) received corticosteroid as an add-on therapy.

When TCZ was initiated, 155 patients (83.3 percent) were on noninvasive ventilation and 63 (33.9 percent) were admitted into semi-critical/critical care units. TCZ was administered within a mean of 12 days from symptoms onset and 4.3 days from hospital admission. Overall, 147 patients (79 percent) survived and 39 (21 percent) died.

Compared with survivors, those who died were older (62.1 years vs 72.4 years; p<0.001) and more frequently had a previous diagnosis of chronic heart failure (1.4 percent vs 12.8 percent; p=0.005) and/or chronic liver disease (2 percent vs 10.3 percent; p=0.036). Significantly more survivors received corticosteroid in combination with TCZ (87.8 percent vs 69.2 percent; p=0.021).

On multivariate Cox analysis, risk factors for mortality were older age (hazard ratio [HR], 1.09; p<0.001), chronic heart failure (HR, 4.4; p=0.003), and chronic liver disease (HR, 4.69; p=0.004).

On the other hand, the use of corticosteroid in combination with TCZ was associated with lower mortality (HR, 0.26; p<0.001).

There were no serious superinfections recorded after a 30-day follow-up.

Despite the encouraging findings, questions remain regarding the best time to administer TCZ and corticosteroid in severe COVID-19, as well as the best regimen and most appropriate doses.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacist - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
04 Oct 2020
Obesity does not appear to be strongly correlated with an increased risk for febrile neutropaenia during levofloxacin prophylaxis in patients with haematological malignancies receiving intermediate-risk myelosuppressive chemotherapy, suggests a study.
Roshini Claire Anthony, 3 days ago

Initiation or switch to the single-tablet regimen of bictegravir/emtricitabine/tenofovir alafenamide (TAF) led to low HIV-1 RNA viral load in people living with HIV (PLHIV), according to the BICSTaR study presented at HIV Glasgow 2020.

09 Nov 2020
Use of corticosteroids appears to be an effective treatment for paediatric drug reaction with eosinophilia and systemic symptoms (DRESS), suggest the results of a recent study. In severe cases, corticosteroids used in conjunction with intravenous immunoglobulin result in fast clinical improvement.
07 Aug 2020
Concomitant treatment with a nonsteroidal anti-inflammatory drug (NSAID) following myocardial infarction (MI) is associated with a higher risk of cardiovascular and bleeding events, a study has shown.